📚 SEM 5 OBSTETRICS & GYNAECOLOGY — COMPREHENSIVE NOTES
For Essays, Viva & Easy Memorisation
1. PRE-CONCEPTIONAL CARE
Definition
Care provided before pregnancy to optimise maternal and fetal outcomes by identifying and modifying risk factors.
Goals (mnemonic: SAFE)
- Screen for chronic illness (diabetes, hypertension, epilepsy, thyroid)
- Assess genetics and family history
- Folic acid supplementation
- Educate on lifestyle (smoking, alcohol, weight)
Key Components
| Component | Detail |
|---|
| Folic acid | 400 mcg/day (standard); 4 mg/day if prior NTD |
| Vaccination | MMR, varicella, Tdap (pre-pregnancy); influenza (in pregnancy) |
| Chronic disease | Optimise DM (HbA1c <6.5%), HTN, seizures, asthma |
| BMI | Ideal 18.5-24.9; counsel on weight loss/gain |
| Medications | Stop teratogens (warfarin, ACE inhibitors, statins, valproate) |
| Genetic screening | Carrier testing (cystic fibrosis, sickle cell, thalassaemia) |
| Infections | Screen HIV, syphilis, rubella, hepatitis B |
| Cervical smear | Ensure up-to-date |
| Mental health | Screen for depression/anxiety |
Müllerian Anomalies
- Should be corrected preconceptionally (e.g., septum resection) to reduce preterm birth risk
Previous Preterm Birth
- Recurrence risk inversely proportional to gestational age of prior preterm birth
- Prepregnancy risk factors found in 40% of preterm births - optimise DM, seizures, asthma, HTN
- Consider: progesterone therapy or cerclage in subsequent pregnancy
Viva tip: "What supplements are given preconceptionally?" → Folic acid (neural tube defect prevention), iron, iodine in deficient areas.
2. FIGO (International Federation of Gynaecology and Obstetrics)
What is FIGO?
- International professional organisation for OB/GYN founded 1954
- Develops staging systems, clinical guidelines, and global health policies
FIGO Staging Systems (Most Tested)
Cervical Cancer (FIGO 2018)
| Stage | Description |
|---|
| I | Confined to cervix |
| IA | Microscopic (IA1: depth <3mm; IA2: depth 3-5mm) |
| IB | Clinically visible or microscopic >5mm |
| II | Beyond cervix, not pelvic wall; upper 2/3 vagina |
| IIA | No parametrial involvement |
| IIB | Parametrial involvement |
| III | Pelvic wall / lower 1/3 vagina / hydronephrosis |
| IVA | Bladder/rectal mucosa involvement |
| IVB | Distant metastases |
Endometrial Cancer (FIGO 2023)
| Stage | Description |
|---|
| I | Confined to uterus/ovaries |
| II | Cervical stroma involvement |
| III | Local or regional spread |
| IV | Bladder/bowel/distant mets |
Ovarian Cancer (FIGO)
| Stage | Description |
|---|
| I | Confined to ovaries |
| II | Pelvic extension |
| III | Peritoneal/lymph node spread beyond pelvis |
| IV | Distant metastases |
FIGO AUB Classification: PALM-COEIN
- Structural: Polyp · Adenomyosis · Leiomyoma · Malignancy/hyperplasia
- Non-structural: Coagulopathy · Ovulatory dysfunction · Endometrial · Iatrogenic · Not classified
Viva tip: FIGO = staging authority for gynaecological cancers. Always state the year of revision when giving staging.
3. PARTOGRAM
Definition
A graphic record of labour progress, maternal and fetal conditions plotted against time. WHO tool.
Components (mnemonic: FILM)
- Fetal: Heart rate (every 30 min), liquor colour, moulding, station, position
- Interventions: Oxytocin, drugs, IV fluids
- Labour: Cervical dilation, uterine contractions, descent of head
- Maternal: Pulse, BP, temperature, urine (output, protein, ketones)
Alert and Action Lines
| Line | Definition |
|---|
| Alert line | Progress <1 cm/hour - increases vigilance |
| Action line | 4 hours to the right of alert line - mandates intervention |
Interpretation
- Normal progress: ≥1 cm/hour cervical dilation in active labour
- Active phase: 4 cm to full dilation (10 cm)
- Latent phase: 0-4 cm (can take up to 8 hours)
- Cervix plotting to the right of action line → consider augmentation or CS
WHO Modified Partogram
- Starts at 4 cm (active phase only) - simpler, widely used in low-resource settings
Benefits
- Prevents prolonged labour
- Reduces unnecessary CS and oxytocin use
- Early identification of obstructed labour
Viva tip: "When do you start a partogram?" → At 4 cm cervical dilation (active phase). "What does crossing the action line mean?" → Augment or deliver.
4. HYPEREMESIS GRAVIDARUM (HG)
Definition
Severe, intractable nausea and vomiting of pregnancy causing:
- Weight loss >5% of pre-pregnancy body weight
- Dehydration + ketonuria/ketonaemia
- Electrolyte disturbances
Epidemiology
- Affects ~1% of pregnancies (vs. 50-90% for simple NVP)
- Peak: 8-12 weeks gestation; may persist to 20 weeks or beyond
Pathophysiology
- Rising hCG and oestradiol levels
- Association with H. pylori infection
- Maternal cytokines implicated
- Molar pregnancy / multiple pregnancy → very high hCG → severe HG
Investigations
| Test | Finding |
|---|
| Urine | Ketones +++, high specific gravity |
| Electrolytes | Hyponatraemia, hypokalaemia |
| ABG | Metabolic alkalosis (contraction) |
| LFTs | Mildly elevated (ALT, AST, bilirubin) - resolves after delivery |
| TFTs | Transient gestational hyperthyroidism (high hCG stimulates TSH receptor) |
Management (step-up)
Step 1 - Outpatient:
- Small, frequent dry meals; ginger; acupressure
- Pyridoxine (vitamin B6) ± doxylamine (Diclegis = first line)
Step 2 - IV Fluids:
- 2 L Ringer's Lactate at 500 mL/hour
- Thiamine (B1) BEFORE any dextrose - prevents Wernicke's encephalopathy
- Then dextrose-containing fluids (D5/0.45% NaCl) once thiamine given
- Antiemetics: metoclopramide, ondansetron, promethazine
Step 3 - Refractory:
- Methylprednisolone 16 mg PO/IV every 8 hours x 3 days (last resort)
- NG enteral nutrition if unable to maintain weight
Step 4:
- TPN (total parenteral nutrition) in severe/refractory cases
Complications
- Maternal: Wernicke's encephalopathy (B1 deficiency), Mallory-Weiss tears, oesophageal rupture, liver failure
- Fetal: Vitamin K deficiency → bleeding diathesis; IUGR in severe cases
Viva tip: "What vitamin must be given before dextrose in HG?" → Thiamine (B1) to prevent Wernicke's. "What is first-line antiemetic?" → Pyridoxine + doxylamine.
5. NORMAL LABOUR
Definition
Spontaneous onset at 37-42 weeks, single fetus, vertex presentation, progress within normal limits, delivery without complications.
Stages of Labour
| Stage | Phase | Events |
|---|
| 1st Stage | Latent: 0-4 cm | Effacement + early dilation |
| Active: 4-10 cm | ≥1 cm/hr dilation |
| 2nd Stage | From full dilation to delivery | Passive + active pushing |
| 3rd Stage | Delivery of placenta | Within 30 min (active mgmt) |
| 4th Stage | First 1-2 hrs post-delivery | Monitoring for PPH |
Mechanisms of Normal Labour (Cardinal Movements)
- Engagement - biparietal diameter at pelvic inlet
- Descent - throughout labour
- Flexion - chin to chest
- Internal rotation - occiput rotates anterior (OA position)
- Extension - head delivered under symphysis
- Restitution - head realigns with shoulders
- External rotation - shoulders rotate
- Expulsion - anterior then posterior shoulder delivered
Active Management of 3rd Stage (AMTSL)
- Oxytocin 10 IU IM (within 1 min of delivery) - gold standard
- Controlled cord traction (Brandt-Andrews manoeuvre)
- Uterine massage after placenta delivered
Normal Findings
- Bloody show - mucus plug + blood, indicates cervical dilation
- Rupture of membranes - SROM or AROM
- Fetal heart rate 110-160 bpm between contractions
- Duration: Primipara 12-18 hrs; Multipara 6-8 hrs
Viva tip: "What is the normal duration of 2nd stage?" → Up to 2 hrs (primip), 1 hr (multip); add 1 hr each with epidural.
6. MISCARRIAGE (Spontaneous Abortion)
Definition
Loss of pregnancy before 20 weeks gestation (WHO: fetus <500g).
Epidemiology
- 15% of clinically recognised pregnancies miscarry
- 20-40% of all pregnancies (including subclinical)
- ~75% occur before 8 weeks
Causes
| Cause | % |
|---|
| Chromosomal aneuploidy | ~60% (most common) |
| Maternal illness (DM, connective tissue disease) | ~15% |
| Uterine anomalies | ~10% |
| Infections (syphilis, HIV) | |
| Progesterone deficiency | |
| Immunological (antiphospholipid syndrome) | |
| Environmental (heavy metals, anaesthetic agents, tobacco) | |
Classification
| Type | Cervical Os | Features |
|---|
| Threatened | Closed | Bleeding + cramps; viable fetus on USS |
| Inevitable | Open | Bleeding + ruptured membranes; tissue not passed |
| Incomplete | Open | Some POC passed; some retained |
| Complete | Closed | All POC passed; empty uterus on USS |
| Missed | Closed | Fetal death, no tissue passed for ≥4 weeks |
| Septic | Variable | Infected POC: fever, tenderness, foul discharge, leukocytosis |
| Recurrent | - | ≥3 consecutive losses → investigate |
Investigations
- Beta-hCG (quantitative, serial every 48 hrs - should double)
- TVS (transvaginal ultrasound) - gold standard; IUP visible at hCG ~1500 mIU/mL
- FBC, blood group, Rh factor
- Urinalysis (UTI → increased fetal wastage)
Management
| Type | Management |
|---|
| Threatened | Reassurance; bed rest (no proven benefit); avoid coitus |
| Inevitable/Incomplete | Surgical (D&C) or medical (misoprostol 600 mcg PO) |
| Complete | Discharge with follow-up; confirm by USS |
| Missed | Misoprostol or surgical evacuation |
| Septic | IV antibiotics + urgent evacuation (do NOT delay) |
| Recurrent | Investigate (karyotype, USS, thrombophilia, APS screen) |
Anti-D Immunoglobulin
- Give anti-D to all Rh-negative women with miscarriage ≥12 weeks (or any surgical evacuation)
Viva tip: "What is the most common cause of miscarriage?" → Chromosomal aneuploidy (~60%). "What type has a closed os with non-viable fetus?" → Missed abortion.
7. BLEEDING IN EARLY AND LATE PREGNANCY
EARLY PREGNANCY BLEEDING (<20 weeks)
Causes (mnemonic: MEI-PC):
- Miscarriage (threatened, inevitable, incomplete, complete, missed)
- Ectopic pregnancy
- Implantation bleeding (normal, ~10-14 days after conception)
- Placenta praevia (rare early)
- Cervical / vaginal lesions (cervicitis, ectropion, polyp)
Ectopic Pregnancy
- Implantation outside uterus (95% fallopian tube)
- Presents: amenorrhoea + pain + bleeding (classic triad)
- Risk factors: PID, previous ectopic, IUD, surgery, ART
- Diagnosis: TVS + quantitative hCG
- If hCG >1500 and no IUP on TVS → ectopic until proven otherwise
- Treatment: Methotrexate (medical, if stable + hCG <5000) or surgical (salpingectomy/salpingostomy)
LATE PREGNANCY BLEEDING (>20 weeks) - Antepartum Haemorrhage (APH)
Definition: Bleeding from the genital tract after 20 weeks and before delivery.
Incidence: ~4% of pregnancies
Major Causes:
| Feature | Placenta Praevia | Abruption Placentae |
|---|
| Pain | Painless | Painful |
| Blood | Bright red, revealed | Dark, may be concealed |
| Uterus | Soft, non-tender | Tender, woody hard |
| Fetal parts | Easily felt | Difficult to feel |
| Presenting part | High/unstable | Normal |
| Fetal distress | Uncommon (initially) | Common |
| Coagulopathy | Rare | Common (DIC) |
| USS | Low-lying placenta | May show retroplacental clot |
Placenta Praevia
- Definition: Placenta implanted over or near internal os
- Grades:
- I: Low-lying (edge near but not covering os)
- II: Marginal (edge reaches os)
- III: Partial (partially covers os)
- IV: Complete (completely covers os)
- Golden Rule: DO NOT do vaginal examination until placenta praevia excluded by USS
- Management: Bed rest, no coitus, CS delivery (grade III/IV)
Abruptio Placentae
- Definition: Premature separation of normally situated placenta
- Associations: Pre-eclampsia/HTN (most common), cocaine, trauma, smoking, thrombophilia, age <20 or >35
- Grades:
- I: Mild (<500 mL; no fetal distress)
- II: Moderate (fetal distress)
- III: Severe (fetal death, maternal shock, DIC)
- Management: Stabilise (blood, FFP, platelets), CTG monitoring, urgent delivery if fetal distress or severe
Viva tip: "What is the rule about vaginal examination in APH?" → Never do VE until placenta praevia excluded by USS.
8. ABDOMINAL PAIN IN EARLY AND LATE PREGNANCY
Early Pregnancy (<20 weeks)
| Cause | Key Features |
|---|
| Ectopic pregnancy | Unilateral pain, amenorrhoea, bleeding; shock if ruptured |
| Miscarriage | Midline cramps + bleeding |
| Ovarian torsion | Acute severe unilateral pain; absent Doppler flow |
| Corpus luteum cyst rupture | Sudden unilateral pain; free fluid |
| UTI / pyelonephritis | Dysuria, fever, loin pain |
| Appendicitis | RIF pain (displaced superiorly by uterus) |
| Round ligament pain | Sharp, brief, bilateral, worse with movement - benign |
| Fibroids (red degeneration) | Localised tenderness over fibroid; fever |
Late Pregnancy (>20 weeks)
| Cause | Key Features |
|---|
| Abruption | Constant severe pain, woody uterus, bleeding |
| Pre-eclampsia / HELLP | Epigastric/RUQ pain (liver capsule distension) |
| Preterm labour | Regular contractions + cervical change |
| Uterine rupture | Sudden severe pain, cessation of contractions, fetal parts palpable outside uterus |
| Acute fatty liver | RUQ pain, jaundice, elevated LFTs, coagulopathy |
| Appendicitis | Displaced upward; may present as RUQ |
| Cholecystitis | RUQ pain, fat intolerance, USS gallstones |
| GERD / Heartburn | Burning, worse supine |
Viva tip: "HELLP syndrome presents with what pain?" → Epigastric or RUQ pain (liver haemorrhage/distension). Always exclude in a 3rd trimester patient with epigastric pain.
9. NORMAL AND ABNORMAL PUERPERIUM
The Puerperium
- Period from 3rd stage of labour to 6 weeks postpartum
- Anatomical, physiological, biochemical return to non-pregnant state
Normal Physiological Changes
| System | Change |
|---|
| Uterus | Involutes: at umbilicus D1 → midway umbilicus-symphysis D5-7 → not palpable by D14 |
| Lochia | Rubra (bloody, D1-4) → Serosa (pink-brown, D4-10) → Alba (pale yellow, D10+) |
| WBC | Leukocytosis up to 20,000/µL in first 24 hrs (normal) |
| Hematocrit | Temporarily raised (diuresis reduces plasma volume) |
| Urine output | Increased (postpartum diuresis) |
| Breast | Engorgement D3-4; colostrum D1-3; mature milk from D3-4 |
| Pulse | Drops within 24 hrs |
| Temperature | May be mildly elevated first 24 hrs (benign) |
Normal Management
- Ambulation as soon as possible (prevents DVT)
- Encourage voiding (avoid retention)
- Oxytocin 10 IU IM or drip if uterus not contracting
- Breastfeeding promotes uterine involution (oxytocin release)
- No vaginal douching; sitz baths for episiotomy
- Meperidine not preferred for breastfeeding mothers (long-acting metabolite)
Abnormal Puerperium
1. Postpartum Haemorrhage (PPH)
| Type | Definition | Causes (4 T's) |
|---|
| Primary PPH | >500 mL blood loss within 24 hrs | Tone (atony 80%), Trauma, Tissue (retained POC), Thrombin (coagulopathy) |
| Secondary PPH | >500 mL or abnormal bleeding 24 hrs to 12 weeks | Retained POC, infection, subinvolution |
Management of Primary PPH:
- Bimanual uterine compression
- Oxytocin 10-40 IU IV (first-line uterotonic)
- Ergometrine 0.5 mg IM (avoid in HTN)
- Carboprost (15-methyl PGF2α) IM
- Misoprostol 1000 mcg rectal (if no other oxytocics)
- Tranexamic acid 1g IV (within 3 hrs of delivery)
- Surgical: B-Lynch suture, uterine artery ligation, hysterectomy (last resort)
2. Puerperal Pyrexia / Sepsis
- Temp >38°C on any 2 of days 1-10 postpartum (excluding first 24 hrs)
- Most common cause: Endometritis (uterine infection)
- Organisms: Group A Streptococcus (most dangerous), E. coli, anaerobes
- Features: fever, uterine tenderness, offensive lochia, leukocytosis
- Treatment: Broad-spectrum IV antibiotics (clindamycin + gentamicin)
3. Postnatal Depression (PND)
| Condition | Onset | Features |
|---|
| Baby blues | Day 3-5 | Mild, self-limiting, tearfulness |
| PND | 2-4 weeks | Persistent low mood, anxiety; treat with CBT/antidepressants |
| Puerperal psychosis | Day 1-2 | Hallucinations, delusions; psychiatric emergency |
4. Mastitis / Breast Abscess
- Mastitis: breast pain, redness, fever; continue breastfeeding; flucloxacillin
- Abscess: fluctuant swelling; surgical drainage + antibiotics
5. Thromboembolic Disease
- Highest DVT/PE risk in first 6 weeks postpartum
- Risk 5-6x higher than non-pregnant state
- Prophylaxis: early ambulation, LMWH in high-risk women
Viva tip: "What are the 4 T's of PPH?" → Tone, Trauma, Tissue, Thrombin. "First-line treatment?" → Oxytocin.
10. HYPERTENSION IN PREGNANCY
Classification
| Type | BP | Features |
|---|
| Gestational HTN | ≥140/90 after 20 wks | No proteinuria/organ dysfunction; resolves by 12 wks postpartum |
| Pre-eclampsia | ≥140/90 after 20 wks + organ dysfunction | Proteinuria (>300 mg/24h) OR AKI, liver dysfunction, neuro signs, thrombocytopenia |
| Eclampsia | Pre-eclampsia + seizures | Convulsions not due to other cause |
| Chronic HTN | ≥140/90 before 20 wks or pre-pregnancy | Persists >12 wks postpartum |
| Superimposed PET | Chronic HTN + new proteinuria/organ dysfunction | After 20 wks |
| White-coat HTN | Office ≥140/90, home <135/85 | ~8% risk of PET (double normal risk) |
Normal BP in pregnancy: Nadir at 18-19 wks (~113/69 mmHg); threshold 140/90 mmHg
Pathophysiology of Pre-eclampsia
Core mechanism: Defective trophoblastic invasion → failure of spiral artery remodelling → uteroplacental ischaemia → release of anti-angiogenic factors (sFlt-1 ↑, PlGF ↓) → systemic endothelial dysfunction
Effects:
- Kidney: Glomerular endotheliosis → proteinuria, AKI
- Liver: Hepatocellular necrosis → elevated transaminases, RUQ pain
- Brain: Microthrombi, oedema → headache, visual disturbance, seizures
- Blood: Thrombocytopenia, microangiopathic haemolysis
- Placenta: Infarction → IUGR, stillbirth
HELLP Syndrome
Haemolysis + Elevated Liver enzymes + Low Platelets
- Severe form of pre-eclampsia
- Presents with epigastric/RUQ pain, malaise, nausea
- Management: Stabilise → deliver (only cure)
Risk Factors for Pre-eclampsia
- Nulliparity, new partner (paternal antigen exposure)
- Previous PET, family history
- Multiple pregnancy, molar pregnancy
- BMI >30, age >40
- Diabetes, CKD, antiphospholipid syndrome, SLE
Management of Pre-eclampsia
Antihypertensives (safe in pregnancy):
- Labetalol (first-line oral) - α/β blocker
- Nifedipine (2nd line)
- Methyldopa (safe, but slow onset)
- Avoid: ACE inhibitors, ARBs (teratogenic)
Severe HTN (≥160/110): IV labetalol or hydralazine (acute control)
Seizure prophylaxis / treatment:
- Magnesium sulphate - drug of choice for eclampsia and prevention of seizures
- Loading: 4g IV over 5-10 min
- Maintenance: 1-2 g/hr IV infusion
- Monitor: urine output, reflexes, respiratory rate
- Antidote: Calcium gluconate 10 mL of 10% IV (for toxicity)
Delivery:
- Only cure for pre-eclampsia
- ≥37 weeks: deliver
- <34 weeks: corticosteroids + aim to reach 34 wks if stable
- Fulminating PET/HELLP: deliver regardless of gestation
Low-dose Aspirin (75-150 mg)
- Prescribed from 12-16 weeks for women at high risk of PET
- Reduces risk of pre-eclampsia by ~15-20%
Viva tip: "What is the antidote to MgSO4 toxicity?" → Calcium gluconate. "What is the only cure for pre-eclampsia?" → Delivery.
11. GESTATIONAL DIABETES MELLITUS (GDM)
Definition
Glucose intolerance first diagnosed during pregnancy, not clearly pre-existing diabetes.
Epidemiology & Pathophysiology
- Affects 5-9% of pregnant women
- Pregnancy = state of progressive insulin resistance (due to HPL, oestrogen, progesterone, cortisol)
- GDM = inability to compensate for this resistance
- Small subset (~6%) may have pre-type 1 DM
Risk Factors
- Obesity (BMI >30), age >25
- Previous GDM, previous macrosomic baby (>4 kg)
- Family history of T2DM
- Ethnic groups: Hispanic, Native American, Asian, African American
- Polycystic ovary syndrome
- Glucosuria
Complications
Maternal:
- Pre-eclampsia, UTI, polyhydramnios
- Operative delivery
- Progression to T2DM (50% within 10 years)
Fetal/Neonatal:
- Macrosomia (LGA >4 kg) → shoulder dystocia risk
- Neonatal hypoglycaemia (most common neonatal complication)
- Respiratory distress syndrome
- Hyperbilirubinaemia, polycythaemia
- Congenital anomalies (if pre-existing DM at conception)
- Stillbirth (if poorly controlled)
- IUGR (with vascular complications)
Screening
Two-step approach (USA/standard):
- 50g Glucose Challenge Test (GCT) - non-fasting, 1 hour
- If ≥140 mg/dL → proceed to diagnostic OGTT
- 100g 3-hour OGTT (fasting)
| Time | NDDG | Carpenter & Coustan |
|---|
| Fasting | 105 | 95 |
| 1 hour | 190 | 180 |
| 2 hour | 165 | 155 |
| 3 hour | 145 | 140 |
| 2 abnormal values = GDM diagnosis | | |
IADPSG one-step approach (75g 2-hour OGTT at 24-28 weeks):
| GDM | Overt DM |
|---|
| Fasting | ≥92 mg/dL | ≥126 mg/dL |
| 1-hour | ≥180 mg/dL | - |
| 2-hour | ≥153 mg/dL | ≥200 mg/dL |
| One abnormal value = GDM (IADPSG) | | |
Management
- Diet and lifestyle - first 1-2 weeks; 30-33 kcal/kg/day; carb restriction
- Blood glucose monitoring - fasting <95 mg/dL; 1 hr post-meal <140 mg/dL; 2 hr <120 mg/dL
- Insulin - if targets not met within 1-2 weeks (safest; doesn't cross placenta in significant amounts)
- Metformin or glyburide - oral agents (controversial; cross placenta)
- Fetal surveillance: growth scans, kick counts, NST in 3rd trimester
- Timing of delivery: 38-40 weeks if well-controlled; earlier if poor control/complications
- Postpartum: 75g OGTT at 6-12 weeks postpartum to exclude persistent DM
Viva tip: "When is GDM screening done?" → 24-28 weeks. "Most common neonatal complication?" → Hypoglycaemia. "What resolves GDM?" → Delivery, but 50% get T2DM within 10 years.
12. NORMAL AND ABNORMAL MENSTRUATION
Normal Menstruation
| Parameter | Normal Range |
|---|
| Cycle length | 21-35 days |
| Duration | 2-7 days |
| Blood loss | 20-80 mL |
| Menarche | 11-15 years |
| Menopause | 45-55 years |
Definitions
| Term | Definition |
|---|
| Amenorrhoea | Absence of periods |
| Oligomenorrhoea | Cycles >35 days |
| Polymenorrhoea | Cycles <21 days |
| Menorrhagia | Heavy bleeding >80 mL (now AUB-HMB) |
| Metrorrhagia | Irregular bleeding between periods |
| Menometrorrhagia | Heavy + irregular bleeding |
| Dysmenorrhoea | Painful menstruation |
| Hypomenorrhoea | Scanty bleeding |
Amenorrhoea
Primary Amenorrhoea
- No period by age 16 with secondary sexual characteristics
- No period by age 14 without secondary sexual characteristics
- Evaluate by age 15 if normal growth + secondary sex characteristics
Causes:
| Category | Examples |
|---|
| Outflow tract | Imperforate hymen, transverse vaginal septum, Müllerian agenesis |
| Gonadal | Turner's syndrome (45,XO), gonadal dysgenesis, ovarian failure |
| Pituitary | Hypopituitarism, prolactinoma |
| Hypothalamic | Kallmann's syndrome, hypothalamic amenorrhoea |
Secondary Amenorrhoea
- Absence ≥3 months (≥6 months in women with previously irregular cycles)
- First exclude pregnancy!
Causes (mnemonic: POSH-C):
- Pregnancy (most common)
- Ovarian - PCOS, premature ovarian insufficiency
- Situational - weight loss, excessive exercise, stress (hypothalamic)
- Hyperprolactinaemia (pituitary adenoma, drugs)
- Chronic illness (thyroid, adrenal, DM)
Abnormal Uterine Bleeding (AUB) - PALM-COEIN
Structural (PALM):
- Polyp
- Adenomyosis
- Leiomyoma (fibroid) - submucosal most likely to cause bleeding
- Malignancy / hyperplasia
Non-structural (COEIN):
- Coagulopathy (von Willebrand disease, ITP, anticoagulants)
- Ovulatory dysfunction (most common = PCOS, hypothyroidism)
- Endometrial (endometritis, endometrial dysfunction)
- Iatrogenic (IUD, hormones, anticoagulants)
- Not yet classified
Dysmenorrhoea
| Type | Description | Cause |
|---|
| Primary | No pelvic pathology; starts 6-12 months after menarche | Excess prostaglandin (PGF2α) → uterine ischaemia |
| Secondary | Underlying pathology | Endometriosis, fibroids, adenomyosis, PID, IUD |
Primary dysmenorrhoea treatment:
- NSAIDs (ibuprofen, mefenamic acid) - inhibit prostaglandin synthesis - first line
- Combined oral contraceptive pill
- Heat, exercise
Polycystic Ovary Syndrome (PCOS) - Key Cause of AUB
Rotterdam criteria (2 of 3):
- Oligo/anovulation
- Clinical/biochemical hyperandrogenism
- Polycystic ovaries on USS (≥12 follicles per ovary, or ovarian volume >10 mL)
Management: Weight loss, COCP, metformin, clomiphene (for fertility)
Menopause
- Natural menopause: 12 consecutive months amenorrhoea at age 45-55
- Premature ovarian insufficiency (POI): before age 40
- Symptoms: hot flushes, night sweats, vaginal atrophy, mood changes
- FSH >40 IU/L; oestradiol <100 pmol/L confirms menopause
Viva tip: "What is the first investigation in secondary amenorrhoea?" → Urine/serum beta-hCG (exclude pregnancy). "PALM-COEIN was developed by whom?" → FIGO. "Primary dysmenorrhoea mechanism?" → Excess PGF2α.
🗂️ QUICK VIVA RECALL SHEET
| Topic | Must-Know Fact |
|---|
| Pre-conceptional care | Folic acid 400 mcg; stop teratogens; optimise DM/HTN |
| FIGO | PALM-COEIN (AUB); staging for Ca cervix/endometrium/ovary |
| Partogram | Alert line = <1 cm/hr; Action line = 4 hrs right of alert |
| Hyperemesis | >5% weight loss; thiamine BEFORE dextrose; Diclegis first-line |
| Normal labour | 4 stages; cardinal movements; AMTSL with oxytocin 10 IU |
| Miscarriage | 60% chromosomal; Os closed = threatened/missed; Os open = inevitable/incomplete |
| Early bleeding | Implantation, ectopic, miscarriage; TVS + hCG |
| Late bleeding | Praevia = painless; Abruption = painful; NO VE before USS |
| Abdominal pain | Early = ectopic/torsion; Late = abruption/HELLP/uterine rupture |
| Puerperium | 6 weeks; PPH 4 T's; Baby blues D3-5; Puerperal psychosis = emergency |
| Hypertension | MgSO4 for eclampsia; antidote = Ca gluconate; Aspirin from 12 wks |
| GDM | Screen at 24-28 wks; 50g GCT then 100g OGTT; neonatal hypoglycaemia; post-delivery OGTT at 6-12 wks |
| Menstruation | Normal 21-35 days; PALM-COEIN; NSAIDs for primary dysmenorrhoea |
Sources: Creasy & Resnik's Maternal-Fetal Medicine; Rosen's Emergency Medicine; Textbook of Family Medicine 9e; Comprehensive Clinical Nephrology 7e; Harrison's Principles of Internal Medicine 22e; Berek & Novak's Gynecology; Tintinalli's Emergency Medicine.